Biopharma Can’t Sue Government for Infringing Safer Opioid Patent

A biopharma can’t sue the U.S. government for infringement of a patent for opioids that relieve pain with fewer harmful side effects, a federal district court ruled Feb. 6 (U.S. v. Cytogel Pharma, LLC,, E.D. La., 2:16-cv-13987, order 2/6/17U.S. v. Cytogel Pharma, LLC, E.D. La., 2:16-cv-13987, order 2/6/17).

The U.S. government filed an action in August 2016 asking the U.S. District Court for the Eastern District of Louisiana to declare the Department of Veterans Affairs (VA) and Tulane University owners of U.S. Patent No. 8,716,436 and ...